It's an exciting time to be in cell therapy manufacturing and commercialization, particularly in the oncology space. This year alone, we've seen the US approval of three cell therapy products: Iovance ...
A team has gained new insights into lithium-sulphur pouch cells at the BAMline of BESSY II. A new picture emerges of processes that limit the performance and lifespan of this industrially relevant ...
The AMT designation gives Cellares’ clients using the Cell Shuttle priority review with the FDA leading to accelerated regulatory filings SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellares, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results